Catheter Precision, Inc. (VTAK)
| Market Cap | 2.58M -17.3% |
| Revenue (ttm) | 1.92M +219.2% |
| Net Income | -13.63M |
| EPS | -6.82 |
| Shares Out | 14.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 814,172 |
| Open | 0.1864 |
| Previous Close | 0.1920 |
| Day's Range | 0.1768 - 0.1928 |
| 52-Week Range | 0.1768 - 3.2000 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About VTAK
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing... [Read more]
Financial Performance
In 2025, Catheter Precision's revenue was $819,000, an increase of 95.00% compared to the previous year's $420,000. Losses were -$17.18 million, -21.18% less than in 2024.
Financial StatementsNews
Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
Landmark international milestone unlocks significant new markets and broadens Flyte's addressable aviation footprint beyond the United States New capabilities connect Flyte's growing Florida network w...
Catheter Precision Proxy statement: Proxy filing
Catheter Precision filed a proxy statement on August 31, 2026, providing details for shareholder voting and corporate governance matters.
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business
Catheter Precision Proxy statement: Proxy filing
Catheter Precision filed a proxy statement on August 21, 2026, providing details for shareholder voting and corporate governance matters.
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing ...
Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations
Catheter Precision Quarterly report: Q2 2026
Catheter Precision has published its Q2 2026 quarterly earnings report on August 14, 2026.
Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event
Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators Collaboration Reflects Flyte's Continued Commitment to Building Relati...
Flyte Achieves Record Revenues in July
July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug. 06,...
Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation
Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens...
Volato AI launches with Flye as first enterprise customer
Volato Group (SOAR) announced the commercial launch and first enterprise deployment of Volato AI. Flyte, a technology-enabled regional air mobility company owned by Catheter Precision (VTAK), will ser...
Volato AI Launches with Flyte as First Enterprise Customer
ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”) today announced the commercial launch and first enterprise deployment of Volato AI, its purpose-built ent...
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with...
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
Exclusive partnership provides 319 Golf Society members with preferred Flyte benefits. FLYTE brings its regional luxury private aviation platform to members of premier private golf clubs across the Un...
Aviation Stocks Lift Off: Flyte (VTAK) Teams Up with Blade Urban Air Mobility
Delta, British Columbia--(Newsfile Corp. - July 22, 2026) - Investorideas.com, a trusted leader in publishing investing ideas for over 25 years issues a snapshot of recent news for aviation stocks, fe...
Flyte Partners with Blade to Expand Vision Jet Distribution
Flyte's Vision Jet Fleet to Be Featured on Blade Platform, Expanding Distribution across One of the Industry's Leading Air Mobility Networks
Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving Equipment
Every FLYTE aircraft combines the Cirrus Vision Jet's CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment .
Catheter Precision announces issuance of two patents
Catheter Precision (VTAK) announced that it has received notification of two patents covering separate technologies owned by the company. One patent issued is for European coverage and is patent no.
Catheter Precision Registration statement: Registration filing
Catheter Precision filed a registration statement on July 6, 2026, providing details about a securities offering with the SEC.
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
Revenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) as Customer Adoption Accelerates Across Key Travel Markets Revenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) a...
Catheter Precision Registration statement: Registration filing
Catheter Precision filed a registration statement on June 22, 2026, providing details about a securities offering with the SEC.
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities acros...
Volato to obtain $2.2M investment lead by Catheter Precision
Volato Group (SOAR) announced the signing of a definitive agreement to obtain a $2.2M strategic investment lead by Catheter Precision (VTAK), and other institutional investors with experience investin...
Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus
ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”), a technology company focused on building scalable software and data solutions that improve the reliabili...
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
Company Deploys Scalable Short-Haul Model into Peak Travel Window as Millions Exit NYC Metro Flagship Routes to Nantucket, Hamptons, and Martha's Vineyard Positioned for Immediate Revenue Acceleration...